Public Clinical Trials Registry
The Friendship Bench Plus trial (FB+Trial) | |
Combining antidepressants with psychological therapy to improve depression outcome in Zimbabwe - the Friendship Bench Plus trial (FB+Trial) | |
Primary Sponsor Details |
|
University Hospital of Psychiatry and Psychotherapy Bern | |
Secondary Sponsor Details |
|
Swiss National science Foundation | |
Rukudzo Mwamuka | |
Study coordinator | |
ruemwamuka.tsungu@gmail.com | |
0777065549 | |
4 Cuba Avenue Mt Pleasant Harare | |
University of Bern | |
Dickson Chibanda | |
Principal Investigator | |
dixon.chibanda@frienshipbench.io | |
0712204107 | |
4 Weale Road Milton Park | |
University of Zimbabwe | |
Zimbabwe |
Foreign |
Depression |
Fluoxetine | |
40000 tablets |
We will include adults ≥18 years with moderate to severe depression defined as PHQ-9 ≥ 11 who are treatment naïve to the FB at the time of recruitment. |
|
Exclusion criteria will be: mild depression defined as PHQ-9 <11; receiving specialist mental health care including antidepressants at the time of recruitment; pregnancy (urine pregnancy test will be performed); history of serious physical health problem (kidney failure, liver failure, serious heart disease, cancer, end-stage AIDS); presenting with high suicidal risk; presenting with psychotic symptoms; or unable to comprehend the nature of the study in either English or Shona (local language). |
|
Our primary outcome will be treatment response after four months defined as ≥ 50% improvement in the PHQ-9 score as compared to baseline Remission after four months defined as PHQ-9<5 will be our key secondary outcome. |
9.0 DESIGN OF THE TRIAL |
|
Controlled | |
If controlled |
|
Yes | |
No | |
No | |
No | |
No | |
No | |
The Friendship Bench psychological intervention | |
No | |
No | |
No | |
No |
296 | |
296 | |
296 |
August 2024 to 31 December 2028 |